Navigation Links
Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors
Date:9/22/2011

HAMPTON, N.J., Sept. 22, 2011 /PRNewswire/ -- Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients in the hospital and ICU settings, today announced that its Chairman and CEO Daniel Tasse has been elected to the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA).

Headquartered in Washington, D.C., PhRMA represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives.

In addition to his membership on the 31-person board, Mr. Tasse will serve on the PhRMA Rare Disease and Emerging Company Committees.  Mr. Tasse brings to these positions an extensive track record in the healthcare industry with a wealth of knowledge and passion for critical care, in particular.

"I'm honored to join this prestigious group of industry leaders and innovators," said Mr. Tasse. "Through my new position on PhRMA's Board of Directors, I look forward to helping to move forward policies that will advance the pharmaceutical industry and continue to benefit patients during this important time for our industry and our economy."

Mr. Tasse also is a member of the Board of Directors and Health Section Governing Board of the Biotechnology Industry Organization (BIO), where he participates on the bioethics, regulatory environment and reimbursement committees.  Additionally, he is a member of the Healthcare Leadership Council and is a member of the Board of Directors of the Roundtable on Critical Care Policy.

Prior to joining Ikaria, Mr. Tasse served as General Manager of the Pharmaceutical Technologies Business Unit of Baxter International.  Earlier in his career, Mr. Tasse held a number of Senior Management positions at GlaxoSmithKline, including that of Vice President and Regional Director for A
'/>"/>

SOURCE Ikaria, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Ikaria® Names New Chief Financial Officer
2. Ikaria® to Present at 31st Annual Cowen and Company Healthcare Conference
3. Ikaria® Launches Next-Generation Drug-Delivery System
4. Ikaria® to Present at 2011 Wedbush Life Sciences Management Access Conference
5. Daniel K. Spiegelman Elected to Board of Directors of Omeros
6. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
7. Governor Daniels Signs Into Law Electronic Tracking Bill
8. Daniels Jumps to No. 2 in Medical Waste Disposal Industry
9. Daniels Sharpsmart Expands U.S. Presence With New Pennsylvania Facility
10. Daniels Sharpsmart Expands U.S. Presence With New Facility in Midwest
11. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...
(Date:5/23/2013)... 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... company, today scheduled a conference call to discuss its ... 2013, ended April 30, 2013. The call will be ... The Company will report financial results for the second ... on Thursday, May 30, 2013. (Logo: ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... CENTER VALLEY, Pa., Dec. 7, 2011 /PRNewswire-iReach/ ... leader in designing and delivering innovative solutions in ... announces the release of Acecide ® -C, a ... exclusively for use in the Olympus Endoscope Reprocessor, ...
... Dec. 7, 2011  Data from the MarginProbe pivotal ... San Antonio Breast Cancer Symposium.  The results were ... Surgery, NYU Langone Medical Center, New York University, ... randomized study, adjunctive use of MarginProbe significantly improved ...
Cached Medicine Technology:Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 2Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection 3MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium 2
(Date:5/23/2013)... Even while being dragged to its destruction inside ... away, sending signals that thwart the development of ... in an early online publication at Nature ... encountered by tumors, the epidermal growth factor receptor ... international team led by scientists at The University ...
(Date:5/23/2013)... be tested in a clinical trial by a biomedical ... disease has failed to work with the same type ... results of a study by University of Florida researchers. ... with the Evelyn F. and William L. McKnight Brain ... of verifying promising research results before investing in clinical ...
(Date:5/23/2013)... researchers have used next generation genomic analysis to determine ... have similar genetic origins, which may help in predicting ... journal Cancer Research . , "This is the ... sequencing in adjacent Gleason patterns in the same tumor ... says ,John Cheville, M.D., Mayo Clinic pathologist and one ...
(Date:5/23/2013)... negative" carries a poor prognosis, with limited treatment options. ... cells the way it,s supposed to. New research from ... to chemotherapy, and identifies a mechanism to rectify that. ... PhD, and his team at Western,s Schulich School of ... functions to promote the death of cancer cells by ...
(Date:5/23/2013)... Rottenstein Law Group LLP, a New York-based nationwide mass ... Center at http://www.rotlaw.com/tylenol , dedicated to issues that ... filing lawsuits. , The painkiller Tylenol (acetaminophen) has ... to a 2009 report from the U.S. Food and ... warned consumers against using more than the recommended dose ...
Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2
... diets also associated with higher income levels, study finds ... higher levels of education and income tend to eat ... are less energy-dense (lower calorie/higher nutrient content), a U.S. ... lower rates of obesity, type 2 diabetes, cardiovascular disease ...
... Tech Rapid Alert System Enables Hospitals to Rapidly Notify Staff, Community ... ... Clark, New Jersey, May 1, 2009 -- Mobile Health Tech, the ... 2.0 of its Hospital Rapid Notification Alert System™. This new release ...
... Female Health Company (NYSE Amex: FHC ) today ... discuss its operating results for the second quarter and first ... Friday, May 8, 2009. The Company expects to report ... earlier the same day. Shareholders and other interested parties may ...
... IL Ankle sprains are a common injury after a fall, ... of those who suffer an ankle sprain will experience chronic ankle ... , A review article published in the May 2009 issue of ... (JAAOS) explains that tendon injuries to the ankle can be ...
... delicious and active Mediterranean lifestyle are curePALM BAY, Fla., ... more likely we are to maintain a healthy diet ... diet than that eaten in the Mediterranean?In his new ... ( published by iUniverse ), Ray Adamcik ...
... Over Prior YearNEW YORK, May 1 HMS (Nasdaq: ... March 31, 2009. For the first quarter of 2009, revenue increased ... period a year ago. Net income for the quarter was $5.7 ... of $3.2 million or $0.12 per fully diluted share for the ...
Cached Medicine News:Health News:More Educated Choose Healthier Foods, But Pay More 2Health News:Hospital Rapid Alert System Supports Swine Flu Pandemic Communications 2Health News:The Female Health Company Schedules Second Quarter Conference Call for May 8, 2009 2Health News:Chronic ankle pain may be more than just a sprain 2Health News:'The Globe's Best Diet: The Metabolic Syndrome Cure' 2Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 2Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 3Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 4Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 5Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 6Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 7Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 8Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 9Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 10Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 11
100% Silicone Foley Catheter Kits 2-Way...
ULTRAMER Foley Catheter...
Foley Catheters (Latex) 2-Way...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Medicine Products: